Cibc World Market Inc. Catalent, Inc. Transaction History

Cibc World Market Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $296,133 - $391,396	-3,144 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $375,928 - $437,236	3,144 New	3,144 $403,000
Q2 2021 Aug 12, 2021	SELL	$100.34 - $115.69 $537,621 - $619,867	-5,358 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $543,890 - $671,196	5,358 New	5,358 $564,000
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $923,328 - $1.52 Million	-19,228 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $710,474 - $1.21 Million	19,228 New	19,228 $999,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.